← Back to Patent Explorer
US4997936A Expired / Lapsed US ⏱️ 0.0 years remaining

2-carbamimidoyl-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids

Assignee: Merck and Co Inc
•
Filing: 1986-08-21
•
Granted: 1991-03-05
•
Expires: 2006-08-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are 2- and 6-substituted-1-carbadethiapen-2-em-3-carboxylic acids having the structure: <IMAGE> wherein R6, and R7 are, inter alia, independently selected from the group consisting of hydrogen, alkyl, alkenyl, aryl and aralkyl; A is a direct, single bond connecting the indicated S and C atoms, or A is a cyclic or acyclic connecting group selected, inter alia, from alkyl, cyclalkyl, aryl, heteroaryl, heteroalkyl; R1 and R2 inter alia, independently selected from hydrogen, alkyl, aryl; additionally, said carbamimidoyl is characterized by cyclic structures achieved by the joinder of the two nitrogen atoms via their substituents and by their joinder to connecting group A; additionally, "carbamimidiums" are disclosed by quarternization of one of the nitrogen atoms of said carbammidoyl. Such compounds as well as their pharmaceutically acceptable salt, ester and amide derivatives are useful as antibiotics. Also disclosed are processes for the preparation of such compounds; pharamaceutical compositions comprising such compounds; and methods of treatment comprising administering such compounds and compositions when an antibiotic effect is indicated.

Inventors

  • 👤 Burton G. Christensen
  • 👤 David B. R. Johnston
  • 👤 Susan M. Schmitt

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 10:34
CPC Classifications
C; C07; C07F; C07F7/00; C07F7/02; C07F7/08; C07F7/10; C07C; C07C205/00; C07C205/39; C07C205/42; C07C205/43; C07D; C07D205/00; C07D205/02; C07D205/06; C07D205/08; C07D477/00; C07D477/02; C07D477/04; C07D477/10; C07D477/12; C07D477/16; C07D477/20; C07D477/26

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 35 words
A compound having the formula: ##STR153## and the pharmaceutically acceptable salt, ester and amide derivatives thereof; wherein: R 6 =H; and R 7 = ##STR154## R 8 is selected from the group consisting of: ##STR155##
Claim 2
Dependent Claim 35 words
A compound having the formula: ##STR153## and the pharmaceutically acceptable salt, ester and amide derivatives thereof; wherein: R 6 =H; and R 7 = ##STR154## R 8 is selected from the group consisting of: ##STR155##

References Cited (Backward Citations)

US4309438A Cited
US4347368A Cited
US4335043A Cited
US4312871A Cited
US4309346A Cited
US4341706A Cited
US4552873A Cited
US4720490A Cited
US4696923A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-03-04 1994-09-03 1995-03-05 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-03-04 1998-09-03 1999-03-05 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-03-04 2002-09-03 2003-03-05 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag